A new self-testing method for early HIV detection using CRISPR technology
A rapid CRISPR-based self-testing platform for early detection of HIV
['FUNDING_OTHER'] · UNIVERSITY OF FLORIDA · NIH-11013398
This study is working on a quick and easy way for people to test themselves for HIV at home using advanced CRISPR technology, so they can get results in about 30 minutes and take action sooner if needed.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11013398 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a rapid and automated self-testing platform that utilizes CRISPR technology for the early detection of HIV. By leveraging engineered CRISPR/Cas systems, the platform aims to identify HIV RNA quickly and accurately, allowing individuals to test themselves without the need for extensive laboratory procedures. The method is designed to provide results in about 30 minutes, significantly improving the chances of early intervention and reducing the risk of transmission. The approach is based on innovative techniques that enhance the sensitivity and specificity of the tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection or those who may have been exposed to the virus.
Not a fit: Patients who are already diagnosed with HIV or those who do not have risk factors for HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a highly accessible and efficient method for early HIV detection, potentially saving lives and reducing transmission rates.
How similar studies have performed: Other research has shown promising results with CRISPR-based diagnostic methods, indicating that this approach could be effective for HIV detection as well.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JAIN, PIYUSH K — UNIVERSITY OF FLORIDA
- Study coordinator: JAIN, PIYUSH K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus